Andres Sanchez-Pernaute

Prof. Dr. Andres Sanchez-Pernaute

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2007 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
ASAndres Sanchez-Pernaute
Andres Sanchez-Pernaute
MHMiguel Angel Rubio Herrera
Miguel Angel Rubio Herrera
EPElia Pérez-Aguirre
Elia Pérez-Aguirre
JPJuan Carlos García Pérez
Juan Carlos García Pérez
LCLucio Cabrerizo
Lucio Cabrerizo
ATAntonio Torres
Antonio Torres

27 August 2010 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
ASAndres Sanchez-Pernaute
Andres Sanchez-Pernaute
MHMiguel Angel Rubio Herrera
Miguel Angel Rubio Herrera
MPMaría Elia Pérez-Aguirre
María Elia Pérez-Aguirre
PTPablo Talavera
Pablo Talavera
LCLucio Cabrerizo
Lucio Cabrerizo
ATAntonio Torres
Antonio Torres

1 September 2015 in Surgery for Obesity and Related Diseases
Verified
Journal Article
Closed access
ASAndres Sanchez-Pernaute
Andres Sanchez-Pernaute
MRMiguel Ángel Rubio
Miguel Ángel Rubio
LCLucio Cabrerizo
Lucio Cabrerizo
ARAna Ramos-Levi
Ana Ramos-Levi
EPElia Pérez-Aguirre
Elia Pérez-Aguirre
ATAntonio Torres
Antonio Torres

1 September 2013 in Surgery for Obesity and Related Diseases
Verified
Journal Article
Closed access
ASAndres Sanchez-Pernaute
Andres Sanchez-Pernaute
MRMiguel Ángel Rubio
Miguel Ángel Rubio
EAElia Pérez Aguirre
Elia Pérez Aguirre
ABAna Barabash
Ana Barabash
LCLucio Cabrerizo
Lucio Cabrerizo
ATAntonio Torres
Antonio Torres

2 July 2009 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
RSRaquel Sánchez-Santos
Raquel Sánchez-Santos
CMCarlos Masdevall
Carlos Masdevall
ABAniceto Baltasar
Aniceto Baltasar
CMCandido Martínez-Blázquez
Candido Martínez-Blázquez
AGAmador García-Ruiz-de-Gordejuela
Amador García-Ruiz-de-Gordejuela
ATAntonio Torres
Antonio Torres

1 November 2008 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
NTNuria García de la Torre
Nuria García de la Torre
MRMiguel A. Rubio
Miguel A. Rubio
EBElena Bordiú
Elena Bordiú
LCLucio Cabrerizo
Lucio Cabrerizo
EAEugenio Aparicio
Eugenio Aparicio
ACAniceto L. Charro
Aniceto L. Charro
Background: Adipocytes regulate blood vessel formation, and in turn endothelial cells promote preadipocyte differentiation through the expression of proangiogenic factors, such as vascular endothelial growth factor (VEGF)-A. Some adipocytokines and hormones also have an effect on vascular development. Objectives: Our objectives were to analyze the relationship between weight and circulating VEGF-A in morbidly obese subjects before and after bariatric surgery, and investigate the relationship between circulating VEGF-A and certain adipocytokines and hormones regulating adipocytes. Methods: A total of 45 morbidly obese women and nine lean females were included in the study. Patients underwent bariatric surgery: vertical banded gastroplasty (n = 17), gastric bypass (n = 17), and biliopancreatic diversion (n = 11). Serum samples for VEGF-A, adiponectin, leptin, ghrelin, and insulin were obtained preoperatively and 9–12 months after surgery. Results: Obese patients showed significantly higher VEGF-A levels than controls (306.3 ± 170.3 vs. 187.6 ± 91.9 pg/ml; P = 0.04), decreasing to 246.1 ± 160.4 after surgery (P < 0.001), with no differences among surgical procedures. In controls there was an inverse correlation between VEGF-A and ghrelin (r = −0.85; P <.01), but not in obese patients. Leptin and insulin concentrations were increased in obese patients, with a significant decrease shown after weight loss with surgery. Conversely, adiponectin concentrations were lower in obese patients, with a significant increase shown after weight loss with surgery. Ghrelin was higher in controls than obese patients, decreasing after gastric bypass and biliopancreatic diversion, but not after vertical banded gastroplasty. Conclusion: Serum VEGF-A levels are significantly higher in obese patients than in lean controls, decreasing after weight loss with bariatric surgery, behaving similarly to other hormones related to adipose mass like leptin and insulin.